Recombinant B2M
Recombinant B2M
Products
| Product Name | Code | Type | Applications | |
|---|---|---|---|---|
| Beta-2-Microglobulin Recombinant (r-hβ2M) | P701-1 | Antigens/Proteins | Biosensor, Clinical Chemistry, Control Manufacture, ELISA, Life Sciences | Buy now |
Request a sample
Recombinant B2M
Blood cancer detection, without compromise.
Upgrade your blood cancer and renal diagnostics with recombinant B2M and deliver reliable, consistent, and scalable results.
Buy Now
Highlights
Our recombinant manufacturing process delivers best in class consistency, so you can trust in the efficacy of our B2M in your assays.
As an ISO 13485 certified manufacturer you can rest assured you have access to a consistent high quality product, batch after batch, saving you time and resources.
We are a leading global manufacturer of IVD reagents, ensuring a seamless supply chain, either from sourcing high-quality raw materials or recombinant production.
Our experts support you every step of the way, building customized assays and tests, ensuring the market success of your diagnostic solutions.
Our new Centre of Excellence strengthens and expands our recombinant manufacturing capabilities to fully cater to our customers and deliver a wider range of critical raw materials.
All the benefits of native, with none of the drawbacks.
Our highly pure recombinant B2M is validated to perform comparable to native, so you can confidently switch to a reliable supply and continue delivering accurate diagnostic results without interruption.
Beta-2 Microglobulin (B2M) helps the immune system recognize and respond to unhealthy cells. It’s used in measuring renal function and diagnosing the progression of diseases like blood cancers.
Native B2M, which is made from human sources, suffers from batch variability and supply issues, leading to unreliable diagnostic results.
BBI Solutions is proud to offer recombinant B2M – an evolution in B2M production – offering all of the benefits of native without any of the drawbacks.
By using high-density fermentation and purification techniques at our ISO 13485 certified facility, we can produce large quantities of recombinant B2M without compromising on quality. This scalability ensures you're able to meet increasing market demand with confidence.
Thanks to its recombinant production, our B2M is created in genetically identical batches, giving you excellent lot-to-lot reproducibility and avoiding the variability associated with native production.
FAQs
What is recombinant B2M and how does it differ from native B2M?
Native B2M is made from human urine whereas recombinant B2M is lab produced through advanced recombinant DNA technology.
Native and recombinant B2M operate in exactly the same way in diagnostic assays.
Why should I switch to recombinant B2M?
We recommend switching because native B2M often suffers from high variability due to genetic differences in the source material. This means test manufacturers have to ensure each batch performs the same as the last in order to avoid errors in diagnosis. It is also increasingly difficult to source, leading to issues around consistent and scalable supply.
Each batch of recombinant B2M however is genetically identical, providing high consistency and reliability.